The diabetes burden of these countries calls for global action in alignment with the UN Sustainable Development Goal 3, which emphasises the provision of universal access to care and affordable essential medicines, and with WHO's Global Target 9 for confronting NCDs, which focuses on the availability of essential medicines, including insulin.1, 2 The Lancet Global Health Commission on high-quality health systems emphasised the importance of developing health systems in LMICs to permit broad access to quality health services.26 This evidence concerns the gene INS and diabetes mellitus.